Ausgabe 2/2024
Inhalt (9 Artikel)
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy
Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida
Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas
Takuma Nakashima, Ryo Yamamoto, Makoto Ohno, Hirokazu Sugino, Masamichi Takahashi, Yusuke Funakoshi, Shohei Nambu, Atsuhito Uneda, Shunsuke Yanagisawa, Takeo Uzuka, Yoshiki Arakawa, Ryosuke Hanaya, Joji Ishida, Koji Yoshimoto, Ryuta Saito, Yoshitaka Narita, Hiromichi Suzuki
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment
Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranai, Yasuharu Akasaki, Masahiro Toda, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis
Takahiro Tsuchiya, Masako Ikemura, Satoru Miyawaki, Yu Teranishi, Kenta Ohara, Tetsuo Ushiku, Nobuhito Saito
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment
Fumi Higuchi, Takeo Uzuka, Hadzki Matsuda, Takuma Sumi, Kayoko Iwata, Takashi Namatame, Masahiro Shin, Hiroyoshi Akutsu, Keisuke Ueki
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature
Manabu Natsumeda, Satoshi Shibuma, Haruhiko Takahashi, Jotaro On, Yoshihiro Mouri, Kaoru Tomikawa, Hidemoto Fujiwara, Jun Watanabe, Yoshihiro Tsukamoto, Masayasu Okada, Rui Takeda, Hiroshi Shimizu, Jun Takizawa, Akiyoshi Kakita, Makoto Oishi
Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma
Kenta Masui, Hiromi Onizuka, Yoshihiro Muragaki, Takakazu Kawamata, Atsushi Kurata, Takashi Komori